Assessment of myocardial fibrosis with cardiovascular magnetic resonance.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21329834.
- Also identified by DOI 10.1016/j.jacc.2010.11.013 and PMC identifier 3081658.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Diffuse interstitial or replacement myocardial fibrosis is a common feature of a broad variety of cardiomyopathies. Myocardial fibrosis leads to impaired cardiac diastolic and systolic function and is related to adverse cardiovascular events. Cardiovascular magnetic resonance (CMR) may uniquely characterize the extent of replacement fibrosis and may have prognostic value in various cardiomyopathies. Myocardial longitudinal relaxation time mapping is an emerging technique that could improve CMR's diagnostic accuracy, especially for interstitial diffuse myocardial fibrosis. As such, CMR could be integrated in the monitoring and therapeutic management of a large number of patients. This review summarizes the advantages and limitations of CMR for the assessment of myocardial fibrosis.
Medical subject headings
- Cardiomyopathies
- Image Interpretation, Computer-Assisted
- Magnetic Resonance Imaging
- Radiographic Image Enhancement